Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.08% to 1,785.30 Indian rupees Monday, on what proved to be an ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the USFDA. Sun Pharma is recalling Morphine Sulfate tablets for failed ...

The NJEDA Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a ...

According to the company's statement, these medications are designed to improve glycemic control in adults with Type 2 Diabetes while also reducing cardiovascular outcomes in the patients.

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal.

Sun Pharmaceuticals Industries Ltd. on Monday, March 10, said it will acquire a Nasdaq-listed immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc.

Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun Pharma’s oncology portfolio with FDA-approved UNLOXCYT for advanced cutaneous ...

The acquisition will be for an upfront cash payment of 4.10 dollars per share, aggregating up to 355 million dollars, the Sun Pharmaceutical Industries Ltd said on March 10. The deal, subject to ...

Sun Pharmaceutical Industries Limited on Monday announced that it will acquire Checkpoint, an immunotherapy and targeted oncology company. According to the company’s exchange filing, Checkpoint ...